Logo image of RIME

ALGORHYTHM HOLDINGS INC (RIME) Stock Fundamental Analysis

NASDAQ:RIME - Nasdaq - US8293225020 - Common Stock - Currency: USD

2.3805  -0.06 (-2.44%)

Fundamental Rating

2

Overall RIME gets a fundamental rating of 2 out of 10. We evaluated RIME against 63 industry peers in the Household Durables industry. RIME has a bad profitability rating. Also its financial health evaluation is rather negative. RIME does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

RIME had negative earnings in the past year.
RIME had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: RIME reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: RIME reported negative operating cash flow in multiple years.
RIME Yearly Net Income VS EBIT VS OCF VS FCFRIME Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M -20M

1.2 Ratios

RIME has a Return On Assets of -287.54%. This is amonst the worse of the industry: RIME underperforms 96.83% of its industry peers.
RIME has a Return On Equity of -671.43%. This is amonst the worse of the industry: RIME underperforms 93.65% of its industry peers.
Industry RankSector Rank
ROA -287.54%
ROE -671.43%
ROIC N/A
ROA(3y)-51.31%
ROA(5y)-31.64%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RIME Yearly ROA, ROE, ROICRIME Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200

1.3 Margins

Looking at the Gross Margin, with a value of 20.72%, RIME is doing worse than 76.19% of the companies in the same industry.
In the last couple of years the Gross Margin of RIME has declined.
RIME does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 20.72%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.83%
GM growth 5Y-4.28%
RIME Yearly Profit, Operating, Gross MarginsRIME Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

More info and screens

3

2. Health

2.1 Basic Checks

RIME does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, RIME has less shares outstanding
The number of shares outstanding for RIME has been increased compared to 5 years ago.
The debt/assets ratio for RIME is higher compared to a year ago.
RIME Yearly Shares OutstandingRIME Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
RIME Yearly Total Debt VS Total AssetsRIME Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

RIME has an Altman-Z score of -8.17. This is a bad value and indicates that RIME is not financially healthy and even has some risk of bankruptcy.
RIME's Altman-Z score of -8.17 is on the low side compared to the rest of the industry. RIME is outperformed by 93.65% of its industry peers.
A Debt/Equity ratio of 0.09 indicates that RIME is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.09, RIME is in the better half of the industry, outperforming 76.19% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Altman-Z -8.17
ROIC/WACCN/A
WACC16.01%
RIME Yearly LT Debt VS Equity VS FCFRIME Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

RIME has a Current Ratio of 1.34. This is a normal value and indicates that RIME is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of RIME (1.34) is worse than 84.13% of its industry peers.
RIME has a Quick Ratio of 1.06. This is a normal value and indicates that RIME is financially healthy and should not expect problems in meeting its short term obligations.
RIME's Quick ratio of 1.06 is in line compared to the rest of the industry. RIME outperforms 58.73% of its industry peers.
Industry RankSector Rank
Current Ratio 1.34
Quick Ratio 1.06
RIME Yearly Current Assets VS Current LiabilitesRIME Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

3

3. Growth

3.1 Past

RIME shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -51.38%.
Looking at the last year, RIME shows a very negative growth in Revenue. The Revenue has decreased by -27.09% in the last year.
Measured over the past years, RIME shows a very negative growth in Revenue. The Revenue has been decreasing by -12.76% on average per year.
EPS 1Y (TTM)-51.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%93.68%
Revenue 1Y (TTM)-27.09%
Revenue growth 3Y-19.95%
Revenue growth 5Y-12.76%
Sales Q2Q%-17.85%

3.2 Future

RIME is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -49.04% yearly.
Based on estimates for the next years, RIME will show a very strong growth in Revenue. The Revenue will grow by 2301.92% on average per year.
EPS Next YN/A
EPS Next 2Y-49.04%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2Y2301.92%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
RIME Yearly Revenue VS EstimatesRIME Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2026 5B 10B 15B 20B
RIME Yearly EPS VS EstimatesRIME Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2026 0 2 4 6 8

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RIME. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RIME Price Earnings VS Forward Price EarningsRIME Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RIME Per share dataRIME EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -50 -100 -150 -200 -250

4.3 Compensation for Growth

RIME's earnings are expected to decrease with -49.04% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-49.04%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

RIME does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALGORHYTHM HOLDINGS INC

NASDAQ:RIME (7/18/2025, 8:09:37 PM)

2.3805

-0.06 (-2.44%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)11-19 2024-11-19/amc
Earnings (Next)N/A N/A
Inst Owners6.98%
Inst Owner Change0%
Ins Owners0.97%
Ins Owner Change68.39%
Market Cap5.98M
Analysts82.86
Price Target5.1 (114.24%)
Short Float %2.66%
Short Ratio0.43
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.26
P/FCF N/A
P/OCF N/A
P/B 1.33
P/tB 1.78
EV/EBITDA N/A
EPS(TTM)-273.57
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-3.66
FCFYN/A
OCF(TTM)-3.63
OCFYN/A
SpS9.19
BVpS1.78
TBVpS1.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -287.54%
ROE -671.43%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 20.72%
FCFM N/A
ROA(3y)-51.31%
ROA(5y)-31.64%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.83%
GM growth 5Y-4.28%
F-Score2
Asset Turnover2.2
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.34
Quick Ratio 1.06
Altman-Z -8.17
F-Score2
WACC16.01%
ROIC/WACCN/A
Cap/Depr(3y)55.88%
Cap/Depr(5y)85.38%
Cap/Sales(3y)0.39%
Cap/Sales(5y)0.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-51.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%93.68%
EPS Next YN/A
EPS Next 2Y-49.04%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-27.09%
Revenue growth 3Y-19.95%
Revenue growth 5Y-12.76%
Sales Q2Q%-17.85%
Revenue Next YearN/A
Revenue Next 2Y2301.92%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-28.84%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-979.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1470.17%
OCF growth 3YN/A
OCF growth 5YN/A